Citations

Showing 10 of 108094 citations.

A102 TOLERABILITY OF USTEKINUMAB IN INDUCTION AND MAINTENANCE FOR THE TREATMENT OF CROHN’S DISEASE
Jacobstein, D, Gasink, Christopher , Sloan, S , Feagan, Brian G. , Loftus, Edward V. , Sattin, Bernie D. , Jacobstein, D, Colombel, Jean‐Frédéric

Mayo Clinic

Journal of the Canadian Association of Gastroenterology | March 1, 2018 | Volume: 1 | Issue: suppl_2 | Pages: 153-154

10.1093/jcag/gwy009.102 Get It

A2 GATHERING AND ASSESSING EVIDENCE TO INFORM A GUIDELINE ON SCREENING FOR COLORECTAL CANCER IN INDIVIDUALS WITH A FAMILY HISTORY
Leddin, Desmond , Tse, F, Samadder, N. Jewel , Tinmouth, Jill , Abou-Setta, Ahmed M , Lieberman, David A. , Leontiadis, Grigorios I. , Barkun, Alan , Marshall, John K. , Singh, Harminder , Telford, Jennifer J. , Wilkinson, Anna N.

Mayo Clinic

Journal of the Canadian Association of Gastroenterology | March 1, 2018 | Volume: 1 | Issue: suppl_2 | Pages: 2-2

10.1093/jcag/gwy009.002 Get It

A19 BACTERIAL PROTEASES INCREASE SENSITIVITY TO DIETARY ANTIGEN THROUGH PAR-2 SIGNALING
Fernandez, A Caminero, Bernier, Steve P., Blanco, Jorge, Surette, Matthew D., Fernández, Alberto Caminero, McCarville, Justin L. , Galipeau, Heather J. , Deraison, Céline , Murray, Joseph A. , Coombes, Brian K. , Ruf, Wolfgang Philipp , Vergnolle, Nathalie , Verdú, Elena F.

Mayo Clinic

Journal of the Canadian Association of Gastroenterology | March 1, 2018 | Volume: 1 | Issue: suppl_2 | Pages: 31-32

10.1093/jcag/gwy009.019 Get It

A271 UNCOVERING GENDER-BASED DIFFERENCES IN UNDIAGNOSED CELIAC DISEASE
Jansson‐Knodell, Claire , Larson, Joseph J. , King, Katherine S. , Murray, Joseph A. , Rubio‐Tapia, Alberto

Mayo Clinic

Journal of the Canadian Association of Gastroenterology | March 1, 2018 | Volume: 1 | Issue: suppl_1 | Pages: 471-471

10.1093/jcag/gwy008.272 Get It

Spontaneous coronary artery dissection in women: What is known and what is yet to be understood
Kok, Susan N., Tweet, Marysia S. , Hayes, Sharonne N.

Mayo Clinic

Clinical Cardiology | March 1, 2018 | Volume: 41 | Issue: 2 | Pages: 203-210

10.1002/clc.22909 | PMID 29493808 Get It

Spontaneous coronary artery dissection is a nonatherosclerotic etiology of acute coronary syndrome, including sudden cardiac death, which frequently affects younger women. This review highlights contemporary knowledge regarding spontaneous coronary artery dissection demographics, prevalence, diagnosis, presentation, and associated conditions and risks, inpatient treatment, major adverse clinical events, and outpatient management decisions.
Vaspin and Omentin-1 in Obese Children with Metabolic Syndrome: Two New Kids on the Block?
Kumar, Seema , Balagopal, Prabhakaran

Mayo Clinic

Metabolic Syndrome and Related Disorders | March 1, 2018 | Volume: 16 | Issue: 2 | Pages: 73-75

10.1089/met.2018.0012 | PMID 29493403 Get It

What the Women's Health Initiative has taught us about menopausal hormone therapy
Chester, Rebecca , Kling, Juliana M. , Chester, Rebecca C, Kling, Juliana M , Manson, JoAnn E.

Mayo Clinic

Clinical Cardiology | March 1, 2018 | Volume: 41 | Issue: 2 | Pages: 247-252

10.1002/clc.22891 | PMID 29493798 Get It

Our understanding of the complex relationship between menopausal hormone therapy (MHT) and cardiovascular disease (CVD) risk has been informed by detailed analyses in the Women's Health Initiative (WHI), the largest randomized, placebo‐controlled trial evaluating MHT in postmenopausal women. Although the WHI demonstrated increased risk of CVD events with MHT in the overall cohort, subsequent secondary analyses demonstrated that these risks were influenced by the woman's age and time since menopause, with lower absolute risks and hazard ratios for younger than older women. As MHT is the most effective treatment for the vasomotor symptoms of menopause, it is important to understand its risks and how to conduct risk stratification for symptomatic women. In addition to reviewing the WHI findings, studies pre‐ and post‐WHI are reviewed to describe the relationship between MHT and CVD risk in menopausal women. The absolute risks of adverse cardiovascular events for MHT initiated in women close to menopause are low, and all‐cause mortality effects are neutral or even favorable for younger menopausal women. The WHI has advanced and refined our understanding of the relationship between MHT and CVD risk. Although MHT should not be used for CVD prevention, absolute risks of CVD are low when MHT is started close to menopause in healthy women and hazard ratios tend to be lower for younger than older women. For women in early menopause and without contraindications to treatment, the benefits of MHT are likely to outweigh the risks when used for menopausal symptom management.
Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation
Abubakar, Mustapha , Chang‐Claude, Jenny , Ali, H. Raza , Chatterjee, Nilanjan , Coulson, Penny , Daley, Frances , Blows, Fiona M., Benı́tez, Javier , Brenner, Hermann , Stegmaier, Christa, Mannermaa, Arto, Sinn, Hans‐Peter , Tollenaar, Rob A.�E.�M. , Seynaeve, Caroline, Figueroa, Jonine D. , Lissowska, Jolanta , Hewitt, Stephen M. , Hooning, Maartje J. , Foekens, Renée , Koppert, Linetta B. , Investigators, kConFab, Bolla, Manjeet K. , Wang, Qin , Jones, Michael E. , Schoemaker, Minouk J. , Keeman, Renske , Easton, Douglas F. , Swerdlow, Anthony J. , García‐Closas, Montserrat , Swerdlow, Anthony J , Lissowska, Jolanta , Sinn, Peter , Jones, Michael E , Brenner, Hermann , García-Closas, Montserrat , Benitez, Javier , Figueroa, Jonine D , Milne, Roger L. , Mannermaa, Arto, Rudolph, Anja , Couch, Fergus J. , Devilee, Peter , Hollestelle, Antoinette , Sherman, Mark E. , Schmidt, Marjanka K. , Pharoah, Paul D.P. , Schoemaker, Minouk J

Mayo Clinic

International Journal of Cancer | March 1, 2018 | Volume: 143 | Issue: 4 | Pages: 746-757

10.1002/ijc.31352 | PMID 29492969 Get It

Limited epidemiological evidence suggests that the etiology of hormone receptor positive (HR+) breast cancer may differ by levels of histologic grade and proliferation. We pooled risk factor and pathology data on 5,905 HR+ breast cancer cases and 26,281 controls from 11 epidemiological studies. Proliferation was determined by centralized automated measures of KI67 in tissue microarrays. Odds ratios (OR), 95% confidence intervals (CI) and p‐values for case–case and case–control comparisons for risk factors in relation to levels of grade and quartiles (Q1–Q4) of KI67 were estimated using polytomous logistic regression models. Case–case comparisons showed associations between nulliparity and high KI67 [OR (95% CI) for Q4 vs. Q1 = 1.54 (1.22, 1.95)]; obesity and high grade [grade 3 vs. 1 = 1.68 (1.31, 2.16)] and current use of combined hormone therapy (HT) and low grade [grade 3 vs. 1 = 0.27 (0.16, 0.44)] tumors. In case–control comparisons, nulliparity was associated with elevated risk of tumors with high but not low levels of proliferation [1.43 (1.14, 1.81) for KI67 Q4 vs. 0.83 (0.60, 1.14) for KI67 Q1]; obesity among women ≥50 years with high but not low grade tumors [1.55 (1.17, 2.06) for grade 3 vs. 0.88 (0.66, 1.16) for grade 1] and HT with low but not high grade tumors [3.07 (2.22, 4.23) for grade 1 vs. 0.85 (0.55, 1.30) for grade 3]. Menarcheal age and family history were similarly associated with HR+ tumors of different grade or KI67 levels. These findings provide insights into the etiologic heterogeneity of HR+ tumors.
Introduction. Update on the treatment of acoustic tumors
Link, Michael J. , Kondziolka, Douglas , Samii, Madjid, Kondziolka, Douglas

Mayo Clinic

Neurosurgical Focus | March 1, 2018 | Volume: 44 | Issue: 3 | Pages: E1

10.3171/2017.12.focus17785 | PMID 29490551 Get It

Retinal signs and 20-year cognitive decline in the Atherosclerosis Risk in Communities Study
Sharrett, A. Richey, Bandeen‐Roche, Karen , Albert, Marilyn , Selvin, Elizabeth , Wasserman, Bruce A. , Selvin, Elizabeth , Rawlings, Andreea M. , Bandeen-Roche, Karen, Klein, Barbara, Klein, Ronald , Selvin, Elizabeth , Deal, Jennifer A. , Gottesman, Rebecca F. , Knopman, David S.

Mayo Clinic

Neurology | March 1, 2018 | Volume: 90 | Issue: 13 | Pages: No page available

10.1212/wnl.0000000000005205 | PMID 29490915 Get It